On 7 May 2026, Miracle Medicine Sdn Bhd achieved three landmark milestones in Guangzhou, China: jointly announcing the peer-reviewed findings of the Porcupine Bezoar immunomodulatory study — published in Pharmaceuticals (MDPI) on 1 April 2026 — with Guangdong Pharmaceutical University; signing a new anti-tumour research collaboration led by Dr Xue Xiao; and completing a partnership agreement with China Central Television's (CCTV) Dialogue with National Brands. The event received simultaneous coverage from over 100 Chinese media platforms, including CCTV.com and Yangcheng Evening News.
achieved in one day
with simultaneous coverage
GDPU began
project launched
Milestone One: Porcupine Bezoar Immunomodulatory Research Announced
Research Press Conference: Immunomodulatory Effects of Porcupine Bezoar
Miracle Medicine Sdn Bhd and Professor Xue Xiao's team from Guangdong Pharmaceutical University jointly announced the findings of their two-year research collaboration. Applying multi-omics technologies, the study systematically elucidated the multi-dimensional immunomodulatory mechanisms of Porcupine Bezoar. Experimental results confirmed that Porcupine Bezoar significantly reverses cyclophosphamide-induced immunosuppression, providing critical scientific evidence for its potential as a standardised clinical immunoadjuvant.
Yangcheng Evening News described the findings as Porcupine Bezoar receiving its "scientific identity card" for entering the modern medical system.
Read the Full Research Breakdown →The Immunomodulatory Effects of Porcupine Bezoar on Cyclophosphamide-Induced Immunosuppression in Rats
Pharmaceuticals 2026, 19(4), 563 · Published 1 April 2026 · MDPI Open Access
Authors: Ji Li, Wenbo Gao, Kien-Seng Lim, Song Lei, Zhipeng Chen, Xiao-Qing Sim, Qinqiang Long*, Xue Xiao*
doi.org/10.3390/ph19040563 →Multi-Omics Technology
Innovatively integrated multi-omics methodology to systematically analyse Porcupine Bezoar's immune regulatory mechanisms.
Chemotherapy Immunity
Confirmed Porcupine Bezoar significantly reverses cyclophosphamide-induced immunosuppression in experimental models.
International Journal
Published in MDPI Pharmaceuticals, Open Access — freely readable and citable worldwide.
Guangdong Pharmaceutical University
Leading Chinese pharmaceutical university with authority in traditional Chinese medicine modernisation.
Milestone Two: New Anti-Tumour Research Collaboration Signed
Signing Ceremony: Evaluation of Anti-Tumour Efficacy and Mechanism of Action of Porcupine Bezoar
On the same day, Miracle Medicine Sdn Bhd and Guangdong Pharmaceutical University formally signed a new research agreement, launching a new project on the anti-tumour efficacy and mechanism of action of Porcupine Bezoar, led by Dr Xue Xiao. Building on the immunomodulatory findings, this new initiative opens new directions in cancer adjuvant therapy research and sets an important precedent for international scientific collaboration in traditional medicine.
Learn About Porcupine Bezoar & Chemotherapy Recovery →Dr Xue Xiao is an associate researcher at Guangdong Pharmaceutical University who was commended by the Guangdong Provincial Party Committee and Provincial Government in January 2026 for advancing industry-technology integration. Since 2019, Dr Xiao's team has been studying Porcupine Bezoar's real-world applications and outcomes in collaboration with Miracle Medicine.
"This is not just a research project — it is a long-term direction we have chosen. We want to use more rigorous, systematic methods to bring Porcupine Bezoar from traditional understanding into the framework of modern scientific research."
Milestone Three: CCTV Dialogue with National Brands Partnership Signed
Partnership Signing: China Central Television's Dialogue with National Brands
Miracle Medicine Sdn Bhd officially completed a partnership signing with CCTV's Dialogue with National Brands programme. Prior to the signing, CCTV's production team was specially dispatched from Beijing — travelling over 4,000km to Malaysia and deep into the Indonesian rainforest — to conduct full A-to-Z on-site filming of Miracle Medicine's Porcupine Bezoar operations: retail, origin ecology, harvesting verification, and quality control.
This was not a routine visit — it was a specially approved, independently commissioned cross-border production.
Read the Full CCTV Traceability Story →
Why Did CCTV Choose Miracle Medicine?
Miracle Medicine was selected for its complete traceability system, rigorous quality management, and its ongoing scientific collaboration with Guangdong Pharmaceutical University — becoming CCTV's benchmark brand representing the modernisation of traditional herbal medicine for the global stage.
Media Coverage: 100+ Chinese Platforms Simultaneously
⭐ Key Media Coverage
CCTV.com — University-Enterprise Collaboration: Porcupine Bezoar Set to Enter Modern Medical System (May 2026) Yangcheng Evening News — Southeast Asia's "Rainforest King" Gets Scientific Backing (May 2026) Guangdong Education Online — Joint Research Results Announced (May 2026) Kan Nanyue — Porcupine Bezoar's "Scientific Identity" Announced (May 2026) Scholat — Research Results Coverage (May 2026) Science Net China — Research Results Coverage (May 2026)This event received simultaneous coverage from over 100 Chinese media platforms. Click below to view the full list.
Philippines